Cas:1144080-27-2 2-Methyl-2-propanyl 2-(1,4-dioxaspiro[4.5]dec-8-yl)hydrazinecarbo xylate manufacturer & supplier

We serve Chemical Name:2-Methyl-2-propanyl 2-(1,4-dioxaspiro[4.5]dec-8-yl)hydrazinecarbo xylate CAS:1144080-27-2 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

2-Methyl-2-propanyl 2-(1,4-dioxaspiro[4.5]dec-8-yl)hydrazinecarbo xylate

Chemical Name:2-Methyl-2-propanyl 2-(1,4-dioxaspiro[4.5]dec-8-yl)hydrazinecarbo xylate
CAS.NO:1144080-27-2
Synonyms:Benzamide,N-(1,4-dihydro-4-oxo-2-quinazolinyl);N-(1,4-Dihydro-4-oxo-2-quinazolinyl)benzamide;N’-(1,4-Dioxa-spiro[4.5]dec-8-yl)-hydrazinecarboxylic acid tert-butyl ester
Molecular Formula:C13H24N2O4
Molecular Weight:272.34100
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:72.31000
Exact Mass:272.17400
LogP:2.29670

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like Benzamide,N-(1,4-dihydro-4-oxo-2-quinazolinyl) chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N’-(1,4-Dioxa-spiro[4.5]dec-8-yl)-hydrazinecarboxylic acid tert-butyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Benzamide,N-(1,4-dihydro-4-oxo-2-quinazolinyl) Use and application,Benzamide,N-(1,4-dihydro-4-oxo-2-quinazolinyl) technical grade,usp/ep/jp grade.


Related News: The suit says that while BRAF kinase inhibitors existed prior to Plexxikon’s discoveries, they were not selective, and Plexxikon’s have a core molecular structure that allows them to bind selectively to kinase created by the BRAF mutation. That allows for higher doses to be administered. 6-Aminocarbonyl-4-[N-ethylsulfonyl-N-(4-picolyl)amino]-2,2-dimethylchroman manufacturers Though the program obtained priority review from FDA back in November, analysts expressed skepticism in July 2020 after it failed to prove superior to the companies’ other drug Lumizyme in improving respiratory function in a Phase III trial. 5-chloro-2,4-dimethyl-aniline suppliers Over the past two to three years, VBP has become “quite a challenge,” AZ’s international and China market chief Leon Wang said on the call. In response, the company has resorted to multichannel marketing, turning to the retail pharmacy market to soften the blow of tender losses. (8R,9S,10R,13S,14S,17S)-17-Hydroxy-10,13-dimethyl-17-(phenylethynyl)-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one vendor & factory.